Full history for every metric is available with a Kvantra account
Amedisys, Inc. (AMED)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,956 | 2,072 | 2,214 | 2,223 | 2,236 | 2,348 | 2,402 |
| Operating profit | $m | 95 | 100 | |||||
| Net profit | $m | 127 | 184 | 209 | 119 | -10 | 43 | 150 |
| EPS reported | $ | 1.31 | 4.53 | |||||
| Operating cashflow per share | $ | 6.78 | 6.78 | |||||
| Capex per share | $ | 0.23 | 0.23 | |||||
| FCF per share | $ | 6.55 | 6.55 | |||||
| Free cash flow | $m | 214 | 234 | |||||
| Net debt | $m | 61 | -301 | |||||
| Book value equity | $m | 1,135 | 1,233 | |||||
| Book value per share | $ | 34.33 | 37.52 | |||||
| Number of shares | m | 33.05 | 32.85 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 69.31 | - | |||||
| P/B LTM | x | 2.62 | 2.69 | |||||
| P/S LTM | x | 1.26 | 1.38 | |||||
| P/FCF LTM | x | 13.86 | 14.18 | |||||
| EV/EBITDA LTM | x | 42.58 | 18.35 | |||||
| EV/Sales LTM | x | 1.33 | 1.26 | |||||
| Earnings Yield LTM | % | 1.44% | 1.31% | |||||
| FCF Yield | % | 7.21% | 7.05% | |||||
| Quality | ||||||||
| ROE | % | 3.81% | 3.93% | |||||
| ROIC | % | 2.44% | 2.44% | |||||
| Operating margin | % | 4.03% | 4.03% | |||||
| Gross margin | % | 43.34% | 43.34% | |||||
| FCF/Sales | % | 9.13% | 9.13% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | +32.84% | |||||
| Sales Growth YoY | % | +5.01% | +4.92% | |||||
| Net Income Growth YoY | % | - | +33.61% | |||||
| FCF Growth | % | +72.16% | +164.71% | |||||
| Operating Profit Growth | % | -39.55% | -48.27% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.47 | 0.52 | |||||
| Net Debt/EBITDA | x | 2.14 | 2.14 | |||||
| EBIT/Net interest | x | 3.07 | 3.07 | |||||
| Net debt/market cap | % | 2.05% | -9.05% | |||||
| Net debt/Equity | x | 0.05 | -0.24 | |||||
| Gross debt/equity | x | 0.41 | 0.37 | |||||
Company overview
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Amedisys, Inc. (AMED)
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free